Recent research indicates that postmenopausal women using testosterone therapy may face an increased risk of cardiovascular issues. The study, shared at The Menopause Society’s 2026 annual meeting in San Diego, analyzed over 6,000 women aged 45 and older. It compared those undergoing testosterone therapy to those not receiving the treatment, excluding participants with a history of cardiovascular disease.
Findings showed 3.8% of women on testosterone therapy experienced a cardiovascular event for the first time, in contrast to 0.5% of women not undergoing the treatment. These events included heart attacks, strokes, heart failure, and other cardiovascular issues.
Role of Testosterone
Produced by the ovaries and adrenal glands, testosterone influences sexual desire, muscle and bone health, mood, and cognition. Anna Cabeca, a Dallas-based OB-GYN and menopause specialist, highlighted the significant difference between the two groups during her comments to Fox News Digital.
The difference between 3.8% and 0.5% is significant enough to warrant attention, but we need to be cautious about interpreting these numbers.– Anna Cabeca
For every 1,000 women on testosterone, approximately 38 experienced cardiovascular events compared to five per 1,000 among those not on the therapy.
Cabeca emphasized that doctors should evaluate patients comprehensively. This includes considering heart history, blood pressure, cholesterol, metabolic health, medications, and family history when evaluating the potential use of testosterone therapy.
Balancing Benefits and Risks
While testosterone can enhance sexual satisfaction in carefully selected postmenopausal women, Cabeca urged the cautious weighing of possible benefits against potential risks.
In instances where testosterone therapy is suitable, meticulous dosing, monitoring, and regular patient assessments are recommended.
Study Limitations
The research is observational, examining outcomes among women already on testosterone rather than utilizing a controlled trial. This methodology enables a connection between testosterone use and cardiovascular events, but doesn’t definitively establish causation.
This is an important safety signal that deserves further investigation, not definitive evidence of causation.– Anna Cabeca
Patient differences such as age, blood pressure, diabetes, cholesterol levels, or other health elements could have influenced heart risk, reflecting the need for more comprehensive research in this area.

The Future of MAHA in American Health Politics
Insulin Cost Caps Gaining Support Amid Rising Prices
A Personal Journey Through Encephalitis
Low-Cost Medication May Benefit Stroke Survivors
The Complex Debate Over Kratom Use in the U.S.
Florida’s Struggle with Dengue Fever and AI Solutions